Kanika Sehgal, MBBS: The Psychological Distress of C Difficile Patients

Video

Treating the disease could reduce the risk of patient distress.

The psychological distress of patients can be a major challenge and hurdles for doctors, particularly those who are not psychiatrists.

But the main source of distress for many is the condition of the disease they are dealing with.

However, in data presented at 2022 Digestive Disease Week Annual Meeting in San Diego, investigators found on significant psychological distress in these patients at the time of symptom development for patients with Clostridioides difficile infection (CDI).

In an interview with HCPLive®, Kanika Sehgal, MBBS, Research Fellow at Mayo Clinic Rochester, explained how the study shed light on how distress manifests in patients.

In the study, the investigators examined adult patients with an index episode of CDI, no history of irritable bowel syndrome or inflammatory bowel disease and all 8 patients developed abdominal pain that was present for at least 1 day per week and was related to change in bowel movement consistency and frequency.

While the results may be surprising, Sehgal said one of the things doctors can do to treat distress is to treat the underlying disease. By treating C difficile infections successfully using first-line therapeutics, Sehgal said there will be a drastic reduction in the risk of psychological distress.

Related Videos
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Lenard A. Adler, MD: “Symptoms of ADHD Need to Go Back to Childhood”
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
© 2024 MJH Life Sciences

All rights reserved.